Short description
Our mission is to introduce innovative, high-quality an intrauterine drug-delivery technology to improve women’s health and quality of life
Description
OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.
In addition to our flagship product, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility.
Total funding
$$43214321
Sign in for full access
Location
Modi'in, HaMerkaz, Israel, Asia
Founded on
February 7, 2011
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccess, No Way, Noaccess, Cannot Access
Sign in for full access
Founders
Keren Leshem